<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03068767</url>
  </required_header>
  <id_info>
    <org_study_id>TZ-105</org_study_id>
    <nct_id>NCT03068767</nct_id>
  </id_info>
  <brief_title>The Relationship Between Vitamin D and Hepatitis B Virus Replication</brief_title>
  <official_title>Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation</source>
  <brief_summary>
    <textblock>
      300 HBV carriers with inadequate serum vitamin D levels were randomized to two groups: one is
      supplied with vitamin D and another without as controls. The markers of HBV replication were
      compared before and after treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized case-control trial. A total of 300 HBV carriers with inadequate vitamin
      D (&lt; 30 ng/mL) level were enrolled. They were randomly divided to two groups: one group
      receiving vitamin D supplement (2000 IU/day) for 2 months and another group as controls. The
      serum vitamin D, HBV DNA and qHBsAg levels were measured at baseline and after vitamin D
      supplement. Whether HBV DNA and qHBsAg have significant change after vitamin D supplement can
      be determined.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Group 1: vitamin D supplement Group 2: controls</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change of serum HBV DNA (IU/mL) before and after vitamin D treatment</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of serum qHBsAg (IU/mL) before and after vitamin D treatment</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Vitamin D and Hepatitis B Virus</condition>
  <arm_group>
    <arm_group_label>Vitamin D group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving vitamin D supplement (2000 IU/day) for 2 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients without receiving vitamin D supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <arm_group_label>Vitamin D group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;20 y/o, HBV carrier

          -  serum vitamin D &lt; 30ng/ml

        Exclusion Criteria:

          -  Other known causes of hepatitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chia-Chi CC Wang, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chia-Chi CC Wang, Master</last_name>
    <phone>+886-2-6628-9779</phone>
    <phone_ext>2315</phone_ext>
    <email>uld888@yahoo.com.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation</name>
      <address>
        <city>New Taipei city</city>
        <zip>23142</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chia-Chi CC Wang, Master</last_name>
      <phone>+886-2-6628-9779</phone>
      <phone_ext>2315</phone_ext>
      <email>uld888@yahoo.com.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2017</study_first_submitted>
  <study_first_submitted_qc>February 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2017</study_first_posted>
  <last_update_submitted>January 21, 2018</last_update_submitted>
  <last_update_submitted_qc>January 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation</investigator_affiliation>
    <investigator_full_name>Chia-Chi Wang</investigator_full_name>
    <investigator_title>Department of Gastroenterology</investigator_title>
  </responsible_party>
  <keyword>HBV DNA, qHBsAg</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis B</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

